EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Houston HealthIT Company Decisio Raises $2.1M in Funds, Adds Lawson to Board

Xconomy Texas — 

Houston’s Decisio Health has raised $2.1 million as part of a $5 million fundraising round and added local healthcare entrepreneur Larry Lawson to its board of directors.

The healthIT company makes software to create a critical care dashboard for ER and ICU staff. Among the investors are Lawson, who will help to ramp up Decisio’s sales efforts, and Declatex, a group family offices that have previously invested in the company.

In January 2015, the company received clearance from the FDA, something rarely sought by medtech companies. Most companies in the electronic health records industry are classified as medical device data systems and typically don’t need the regulatory sign-off.

The company was formed in April 2013 and had a successful pilot at Houston’s Memorial Hermann Hospital. Gray Hancock, Decisio’s chief operating officer, told me that the company has signed a contract with a major hospital system—he does not yet have permission to reveal the name—and is close to finalizing another contract with the University of Cincinnati.